The global genomics
market size is expected to reach USD 27.6
billion by 2025, according to a new report by Grand View Research, Inc.,
progressing at a CAGR of 9.7% during the forecast period. Over the past few
years, there have been significant changes in disease management processes due
to simultaneous advancements in genomics and personalized medicine. There has
been a gradual growth in usage of genomic studies in clinical practices, which
is reflected by growing trend of targeted therapies.
Results from genomic studies enable a
better understanding of diseases and underlying mechanisms for researchers,
physicians, and consumers. This facilitates evidence-based decision-making and
thus, helps improve personalized treatment regime. In addition, technological
advancements in data analysis tools are motivating healthcare community to
create precision-based therapies from surplus, available DNA data.
Advancements in genomics and associated technologies
are significantly impacting crop genetics. Technological advancements in
sequencing facilitate genomes & transcriptomes sequencing for several
crops. Although a reference genome exists for several crops, resequencing and
gene expression studies are required for in-depth study of key genes
contributing to desired trait. Implementation of this information in crop
breeding helps in development of advanced crops.
Companies are involved in strategic
alliances with global as well as local entities to boost their revenue
generation and enhance their share in the market. For instance, in March 2017,
Foundation Medicine collaborated with Bristol-Myers Squibb Company. Through the
collaboration, the latter was able to deploy former’s molecular information solutions
and comprehensive genomic profiling for identification of predictive
biomarkers, such as Microsatellite Instability (MSI) and Tumor Mutational
Burden (TMB), to accelerate its immunotherapy clinical trials. Such initiatives
are aimed at increasing the adoption of genomic information in cancer
management.
Access Research Report
of Genomics Market@:
www.grandviewresearch.com/industry-analysis/genomics-market
www.grandviewresearch.com/industry-analysis/genomics-market
Further
Key Findings From the Report Suggest:
· High volume requirement and high cost of
specific reagents contribute to substantial revenue growth. Companies are
incorporating the trend of offering varied reagents that simplify workflow
process
· NGS-based services hold a major share in
the genomics services segment due to their rapid adoption of whole genome
sequencing and application of sequence databases for disease screening and
prognosis
· Biomarkers exhibit high clinical potential
and efficiency across treatment of wide range of diseases. Use of predictive
biomarkers for diagnosis and monitoring take cancer eradication a step further.
Moreover, organizations and programs such as National Biomarker Development
Alliance (NBDA) are actively participating in development of novel biomarkers
for cancer diagnosis
· Growing interest of pharmaceutical and
biotechnology companies in genomics is expected to drive the market in the
coming years.
· As patients are focusing more on their
health, direct-to-consumer (DTC) laboratory testing is increasingly gaining
popularity. DTC genetic tests enable consumers to access information about
their genetics without necessarily including healthcare professionals in the
process
· Asia Pacific is the most promising region,
exhibiting a CAGR of 12.7% during the forecast period. The growth of the region
can be attributed to improving healthcare infrastructure
· Some of the key players in the market are
BGI; Agilent Technologies; Thermo Fisher Scientific, Inc.; Bio-Rad
Laboratories, Inc.; Foundation Medicine, Inc., 23andMe, Inc.; Danaher;
Illumina, Inc.; Pacific Biosciences; Oxford Nanopore Technologies.; F.
Hoffmann-La Roche Ltd.; and Myriad Genetics, Inc.
· Market participants are engaged in making
the technology available to users at a lower price and in a compact form.
Browse more reports of this category by Grand View
Research at:
www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the
global genomics market on the basis of product & service, application &
technology, end-use, and region:
Genomics Product and Service Outlook
(Revenue, USD Million, 2014 - 2025)
·
Products
o
Instruments/Systems/Software
o
Consumables & Reagents
·
Services
o
Core Genomics Services
o
NGS-based Services
o
Biomarker Translation Services
o
Computational Services
o
Others
Genomics Application & Technology
Outlook (Revenue, USD Million, 2014 - 2025)
·
Functional Genomics
o
Transfection
o
Real-time PCR
o
RNA interference
o
Mutational analysis
o
SNP analysis
o
Microarray analysis
·
Epigenetics
o
Bisulfite sequencing
o
Chromatin immunoprecipitation (ChIP &
ChIP-Seq)
o
Methylated DNA immunoprecipitation (MeDIP)
o
High resolution melt (HRM)
o
Chromatin accessibility assays
o
Microarray analysis
·
Pathway Analysis
o
Bead-based analysis
o
Microarray analysis
o
Real-time PCR
o
Proteomics tools (2-D PAGE; yeast 2-hybrid
studies)
·
Biomarker Discovery
o
Mass spectrometry
o
Real-time PCR
o
Microarray analysis
o
Statistical analysis
o
Bioinformatics
o
DNA sequencing
·
Others
Genomics End-use Outlook (Revenue, USD
Million, 2014 - 2025)
·
Clinical Research
·
Academic and Government Institutes
·
Hospitals and Clinics
·
Pharmaceutical and Biotechnology Companies
·
Other End Users
Genomics Regional Outlook (Revenue, USD
Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
·
Middle East and Africa (MEA)
o
South Africa
Access Press Release of
Genomics Market@: www.grandviewresearch.com/press-release/genomics-market-analysis
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment